KR0137897B1 - Health food containing leaf of eucommia ulmoides oliver - Google Patents

Health food containing leaf of eucommia ulmoides oliver

Info

Publication number
KR0137897B1
KR0137897B1 KR1019950005354A KR19950005354A KR0137897B1 KR 0137897 B1 KR0137897 B1 KR 0137897B1 KR 1019950005354 A KR1019950005354 A KR 1019950005354A KR 19950005354 A KR19950005354 A KR 19950005354A KR 0137897 B1 KR0137897 B1 KR 0137897B1
Authority
KR
South Korea
Prior art keywords
extract
weight
leaf
experimental group
herbal
Prior art date
Application number
KR1019950005354A
Other languages
Korean (ko)
Other versions
KR960033299A (en
Inventor
안종현
이병순
김영걸
Original Assignee
한동근
주식회사태평양
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한동근, 주식회사태평양 filed Critical 한동근
Priority to KR1019950005354A priority Critical patent/KR0137897B1/en
Publication of KR960033299A publication Critical patent/KR960033299A/en
Application granted granted Critical
Publication of KR0137897B1 publication Critical patent/KR0137897B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/3262Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332Promoters of weight control and weight loss

Abstract

본 발명은 두충엽을 주원료로 함유한 건강식품 조성물에 관한 것으로, 더욱 상세하게는 두충엽을 주원료로 함유하고, 여기에 감잎, 산사자, 월견자, 결명자, 황금, 동규자 등의 생약재를 1종 또는 2종 이상 함유함으로써, 우수한 체중감량 효과를 얻을 수 있을 뿐만 아니라, 혈중 콜레스테롤 농도 및 중성지방의 농도를 현저하게 저하시켜 비만에 의해 유발되는 동맥경화, 고협암 등의 성인병의 예방 효과를 부여할 수 있는 건강식품 조성물에 관한 것이다.The present invention relates to a health food composition containing the two young leaves as a main raw material, more specifically, the two young leaves containing the main raw material, and here, one or more herbal medicines such as persimmon leaf, mountain lion, moon dog, gyeolja, golden, Donggyuja By containing two or more kinds, not only an excellent weight loss effect can be obtained, but also a significant decrease in the concentration of cholesterol and triglycerides in the blood, thereby imparting a preventive effect on adult diseases such as arteriosclerosis and high sciatic cancer caused by obesity. The present invention relates to a health food composition.

Description

두충엽을 주원료로 함유한 건강식품 조성물Health Food Composition Containing Tobacco Leaf as Main Ingredient

본 발명은 두충엽을 주원료로 함유한 건강식품 조성물에 관한 것으로, 더욱 상세하게는 두충엽을 주원료로 함유하고, 여기에 감잎, 산사자, 월견자, 결명자, 황금, 동규자 등의 생약재를 1종 또는 2종 이상 함유함으로써, 우수한 체중감량 효과를 얻을 수 있을 뿐만 아니라, 혈중 콜레스테롤 농도 및 중성지방의 농도를 현저하게 저하시켜 비만에 의해 유발되는 동맥경화, 고혈압 등의 성인병의 예방 효과를 부여할 수 있는 건강식품 조성물에 관한 것이다.The present invention relates to a health food composition containing the two young leaves as a main raw material, more specifically, the two young leaves containing the main raw material, and here, one or more herbal medicines such as persimmon leaf, mountain lion, moon dog, gyeolja, golden, Donggyuja By containing two or more kinds, not only an excellent weight loss effect can be obtained, but also a significant decrease in the concentration of blood cholesterol and triglycerides, which can impart prophylactic effects such as arteriosclerosis and hypertension caused by obesity. It relates to a health food composition.

현대를 살아가는 사람들은 경제적 풍요로 인한 생활환경의 변화와 식생활의 서구화로 인한 열량의 과다섭취 및 운동부족 등에 기인하여 체지방 증가로 인한 비만형상을 보이는 이들이 급격히 증가하고 있으며, 이러한 비만현상은 당뇨병이나 동맥경화, 고혈압 등의 합병증을 유방하거나 악화시키는 매우 위험한 인자로 되어 있다.People living in modern times are rapidly increasing obesity due to body fat increase due to changes in living environment due to economic abundance, excessive intake of calories due to westernization of diet and lack of exercise, and such obesity is diabetes or artery It is a very dangerous factor to breast or worsen complications such as hardening and hypertension.

이렇게 비만은 건강과 곧 직결되므로 비만의 예방 및 해소가 이제는 젊은 여성들만의 소망이 아니라, 모든 이의 건강을 지키기 위한 필수요소로서 지적되고 있다.Since obesity is directly linked to health, prevention and resolution of obesity are now pointed out as a necessity for protecting the health of everyone, not just the wishes of young women.

현재 체중감량을 위한 방법으로서 식사요법이나 운동요법, 체중감량 보조제등을 복용하는 방법등이 있으나, 식사요법의 경우 식사량을 줄이거나 계산된 열량의 식사를 하여 일시적 효과는 있지만 정상적인 식사를 다시할 경우 체중이 다시 증가하는 단점이 있으며, 또한 운동 요법은 격력한 운동에 의해 체내 지방을 연소시킴으로써 체중감량 효과를 얻을 수 있는 것으로, 꾸준한 운동에 의해서만 효과를 얻을 수 있고, 운동을 위해 별도의 시간을 내야 하는 문제점이 있으며, 대체적으로 큰 고통을 수반하게 된다. 체중감량 보조제를 복용하는 방법으로 대표적인 것으로는 이뇨제, 설사제, 식욕억제제, 섬유질제재 등이 있으나, 이뇨제나 설사제의 경우 몸안의 수분을 감소시켜 일시적인 체중감소 효과를 갖게 하나 비만의 주원인은 지방질의 제거와는 무관하여 근본적인 치료는 될 수 없으며, 뇌속의 포만 중추신경을 자극하여 식욕을 억제하는 효과를 갖는 식욕억제제의 경우 염산페닐 프로파놀아민이 주성분으로 협압상승이나 신경과민, 불면증 등의 부작용이 올 수도 있다. 또한 포만감만을 주고 영양가가 거의 없는 섬유질을 가공한 섬유질제재는 장기간 과다 복용시 영양결핍 등을 유발하기도 한다.Currently, there are methods for weight loss, such as taking meal therapy, exercise therapy, and weight loss supplements.However, in the case of meal therapy, reducing the amount of meal or eating a calorie of the calculated calories is temporary effect, but if you resume normal eating There is a disadvantage in that the weight increases again, and exercise therapy can gain weight by burning fat in the body by vigorous exercise, which can be obtained only by steady exercise, and requires extra time for exercise. There is a problem, and it usually involves a lot of pain. The most common methods of taking weight loss supplements include diuretics, diarrhea, appetite suppressants, and fibrous medications. Diuretics and diarrhea have temporary effects of weight loss by reducing moisture in the body. It is irrelevant to the elimination and cannot be treated fundamentally.In the case of an appetite suppressant that has the effect of suppressing appetite by stimulating the satiety central nerve in the brain, phenyl propanolamine is mainly composed of side effects such as increased pressure, nervousness and insomnia. May come. In addition, fibrous materials processed with fiber that gives only a feeling of satiety and little nutritional value may cause nutritional deficiency in long-term overdose.

이에, 본 발명자들은 상기와 같은 식사요법이나 운동요법에 수반되는 식사제한이나 격렬한 운동 등의 고통없이 체중감량 효과를 부여할 수 있으며, 종래의 체중감량 보조제와는 달리 인체 안전성이 우수하여 부작용의 염려가 없는 건강식품 조성물을 제공하기 위하여, 예로부터 복용되어 오고 있어 오랜세월 두고 그 안전성이 입증되어 온 생약재를 중심으로 연구를 거듭한 결과, 여러 실험을 통해 체중 감량 효과가 있는 것으로 기대되는 생약재를 선정함으로써 본 발명을 완성하게 되었다.Thus, the present inventors can give a weight loss effect without pain, such as diet restrictions or vigorous exercise associated with the above-described diet therapy or exercise therapy, unlike the conventional weight loss supplements are excellent in human safety and fear of side effects In order to provide a healthy food composition that does not have a long history of research, focusing on herbal medicines that have been taken for a long time and have proven their safety, we have selected herbal medicines that are expected to be effective in weight loss through various experiments. Thus, the present invention has been completed.

본 발명은 예로부터 고혈압, 스트레스, 관절염, 숙취 등의 각종 질병에 유용한 약재로서 음용되어 왔으며, 최근 들어 임상적인 실험을 통해 그의 비만방지 효과가 입증되어 주목받고 있는 두충차를 주성분으로 함유한 건강식품 조성물을 제공한다.The present invention has been used as a medicine for a variety of diseases, such as high blood pressure, stress, arthritis, hangover, etc., and the health food composition containing soybean tea as a main ingredient, which has recently been proven attention in preventing clinical obesity through clinical experiments To provide.

한편, 최근 들어 발표되는 문헌에 의하면, 인체내 소화 효소 중 전분을 분해하여 말토스와 글루코스 등을 생성하는 a-아밀라제 (a-amylase)와 지방을 분해하는 리파제(liase)등의 소화효소의 활성을 저해시키는 경우, 탄수화물이나 지방의 소화흡수를 막거나 또는 소화속도를 지연시킬 수 있으며, 이로써 궁극적으로 섭취되는 열량을 감소시킬 수 있으며, 체내 축적되는 지방을 감소기켜 다이어트 효과를 얻을 수 있음이 밝혀졌다.On the other hand, according to a recently published document, the activity of digestive enzymes, such as a-amylase, which breaks down starch from the human digestive enzymes to produce maltose and glucose, and liase, which breaks down fat. Inhibition of digestion of carbohydrates or fats can slow down or slow down digestion, which can ultimately reduce the amount of calories ingested and reduce the amount of fat stored in the body, resulting in a dietary effect. lost.

(참고문헌 : 日本食品工業會誌 Vol. 41, No. 8, p561, 1994;(Reference: Japanese Food Co., Ltd. Vol. 41, No. 8, p561, 1994;

日本食品工業會誌 Vol. 40, No. 3, p214, 1993; 日本 食品 工業 會 誌 Vol. 40, no. 3, p214, 1993;

New Food Industry Vol. 36, No. 9, p1, 1994; New Food Industry Vol. 36, No. 9, p 1, 1994;

New Food Industry Vol. 35, No. 12, p1, 1993; New Food Industry Vol. 35, No. 12, pi, 1993;

生樂學雜誌 Vol. 39, No. 4, p261, 19953; 生 樂 學 雜誌 Vol. 39, No. 4, p261, 19953;

식품공업, p23, 1994. 10. 30) Food Industry, p23, Oct. 30, 1994)

이에, 본 발병자들은 a-아밀라제와 리파제의 효소활성을 저해하는 작용을 갖고 있는 천연 생약재에 대한 광범위한 검색을 실시한 결과, 감잎, 신사자, 월견자, 결명자, 황금, 동규자가 이러한 소화효의 활성 저해 능력이 우수함을 발견하였으며, 또한 이들 소화효소를 저해하는 능력을 지닌 생약재들을 두충엽에 첨가, 혼합하여 복용하였을때, 체중감량의 효과는 물론, 혈중지방과 혈중콜레스테롤 농도의 감소효가 두충엽을 단독으로 복용하였을 때 보다 우수한 상승효과를 나타내는 것을 발견하고, 본 발명을 완성하게 되었다.Therefore, the present inventors conducted an extensive search for natural herbal medicines that inhibit the enzymatic activity of a-amylase and lipase. It has been found to have excellent ability, and when herbal medicines with the ability to inhibit these digestive enzymes are added to and mixed with the two lobe leaves, the weight loss effect, as well as the effect of reducing the blood fat and cholesterol concentrations of the two lobe leaves alone When taken as found to show a superior synergistic effect, the present invention was completed.

즉, 본 발명의 목적은 체중감량 효과가 있다고 알려진 두충엽을 주원료로 함유하며, 여기에 소화효소의 활성을 저해하는 작용을 갖는 것으로 입증된 감잎,산사자, 월견자, 결명자, 황금 및 동규자 중에서 선택된 1종 이상의 생약재를 함유함으로써, 우수한 체중감량 효과를 얻을 수 있을 뿐만 아니라, 혈중 콜레스테롤 농도 및 중성지방의 농도를 현저하게 저하시켜 비만에 의해 유발되는 동맥경화, 고혈압 등의 성인병의 예방 효과를 부여할 수 있는 건강식품 조성물을 제공하는 것이다.In other words, the object of the present invention contains the two main leaves, which are known to have a weight loss effect, selected from persimmon leaves, hawthorn, moon dogs, deficiencies, gold and sage By containing one or more herbal medicines, not only can an excellent weight loss effect be obtained, but also a significant decrease in the concentration of cholesterol and triglycerides in the blood, thereby imparting the prevention of adult diseases such as arteriosclerosis and hypertension caused by obesity. It is to provide a health food composition that can be.

본 발명에 따른 건강식품 조성물은 식사요법이나 운동요법에 수반되는 식사제한이나 격렬한 운동 등의 고통이 없으며, 종래의 체중감량 보조제와는 달리 인체 안전성이 우수하여 부작용의 염려 없이 체중감량 효과를 부여할 수 있다.The health food composition according to the present invention has no pain such as dietary restrictions or vigorous exercise accompanying dietary therapy or exercise therapy, and unlike conventional weight loss supplements, it is excellent in human safety and gives weight loss effects without fear of side effects. Can be.

이하, 본 발명의 조성물의 유효성분에 대하여 설명한다.EMBODIMENT OF THE INVENTION Hereinafter, the active ingredient of the composition of this invention is demonstrated.

본 발명에 사용된 두충(Eucommia ulmoides oliver)은 두충나무고 (Eucommiaceae)에 속하는 낙엽교목으로, 중국 사천성(四川省)부근이 원산지이며 줄기나 엽둥이 예로부터 차로서 음용되어 왔으며, 비타민 C가 많이 함유되어 있고 부신의 기능을 높이는 작용과 함께 심장병과 당뇨병, 동맥경화 예방에 효과가 있다.In the present invention, the worm (Eucommia ulmoides oliver) is a deciduous tree belonging to the Eucommiaceae, and it is native to Sichuan Province in China and has been drinking as a tea from stems and leaves since ancient times. Containing a lot of functions to increase the function of the adrenal gland is effective in preventing heart disease, diabetes, arteriosclerosis.

월견자는 달맞이꽃(Oenothera lamarckiana Seringe)의 종자를 말하는 것으로, 한방에서는 예로부터 해열과 소염의 목적으로 사용되었고, 리놀산(Linoleic acid)과 리놀렌산(Linolenic acid)등의 불포화 지상산을 주요성분으로 함유하고 있으며, 고혈압에 효과가 있다.Moonflower is a seed of evening primrose (Oenothera lamarckiana Seringe), which has been used for antipyretic and anti-inflammatory purposes in Korea, and contains unsaturated terrestrial acid such as linoleic acid and linolenic acid as main components. It is effective in hypertension.

산사자는 산사나무(Crataegus pinnatifiad Bumge)의 종자를 말하는 것으로, 항균작용과 함께 혈관확장작용 및 혈압강하작용을 하는 것으로 알려져 한방에서는 산후조리 및 고혈압, 동맥경화와 심근계통의 치료 등에 사용하고 있다.The hawthorn refers to the seeds of the hawthorn (Crataegus pinnatifiad Bumge), and is known to act as an antibacterial action and dilate the blood vessels and lower blood pressure, and is used in the treatment of postpartum care and hypertension, arteriosclerosis and myocardial system in oriental medicine.

결명자(Cassia tora Linne)는 체내에 신진대사와 혈액순환을 왕성하게 할 뿐만 아니라 눈을 발게 해주고 장의 연동운동을 촉진하는 효과가 있다. 한방에서는 심장병과 당뇨병 및 고혈압과 만성적인 변비의 치료등에 사용하고 있다.Cassia tora Linne not only stimulates metabolism and blood circulation in the body, but also opens the eyes and promotes intestinal peristalsis. Oriental medicine is used for the treatment of heart disease, diabetes, high blood pressure and chronic constipation.

황금(Sutellaria baicalensis Georgi)은 꿀플과에 속하는 식물로서 뿌리를 사용하며, 본 발명에서는 뿌리의 색상이 황색으로 충실하며 쓴맛이 있는 것을 사용한다.Golden (Sutellaria baicalensis Georgi) uses the root as a plant belonging to the family Naples, and in the present invention, the root color is faithful to yellow and has a bitter taste.

한방에서 주로 혈압강하, 해열, 이뇨, 항균의 목적으로 사용한다.It is mainly used for the purpose of lowering blood pressure, fever, diuresis and antibacterial medicine.

동규자(Malva verticillata Linne)는 아옥의 종자를 말하는 것으로, 이뇨작용과 함께 장의 연동운동을 활발히 하는 효과가 있어서 한방에서는 변비의 치료 및 이뇨의 목적으로 사용하고 있다.Dong Kyuja (Malva verticillata Linne) refers to the seeds of the jade, diuretic and intestinal peristalsis is active to the effect of oriental medicine is used for the treatment of constipation and diuresis.

두충엽에 이들 생약재들을 첨가, 혼합하면 체중감량의 효과가 더욱 상승하게 되는데, 아직까지 그 메카니즘에 대해서는 확실하지 않으나 두충의 체중감량 효과 및 각 생약재들의 생체내 소화효소의 저해효과가 신진대사 과정에서 복합적인 상승효과를 일으켜 월등한 체중감량효과 및 혈중지방과 혈중콜레스테롤 감소 효과를 보이는 것으로 생각되고 있다.Addition and mixing of these herbal medicines on the larvae will increase the weight loss effect. However, the mechanism of weight loss of the larvae and the inhibitory effects of the digestive enzymes in vivo of each medicinal herb on the metabolism process are not yet clear. It is believed to produce a complex synergistic effect, resulting in an excellent weight loss effect and a reduction in blood fat and cholesterol.

본 발명의 조성물은 체중감량 효과가 우수한 두충엽과, 소화효소의 활성 저해 작용에 의해 비만방지 효과를 부여할 수 있는 감잎, 산사자, 월견자, 결명자, 황금 및 동규자 중에서 선택된 1종 이상의 생약재를 함유하며, 제제의 형태는 차, 음료, 과립, 정제, 경질 캡슐 등으로 할 수 있으며, 특별히 한정되지 않는다. 이때, 생약재는 두충엽과 생약재를 합한 중량에 대해 30중량% 이하가 되는 양으로 함유하는 것이 효과면에서 바람직하다. 생약재를 상기한 30중량%를 초과하는 양으로 함유하는 경우, 체중감량 효과에 있어서 뚜렷한 효과를 얻을 수 없으며, 이는 후술하는 실험예에 의해 입증된다.The composition of the present invention contains a two-leaf lobe excellent in weight loss effect, and one or more herbal medicines selected from persimmon leaves, hawthorn, walnuts, gwanjakja, golden and Donggyuja that can give the anti-obesity effect by the inhibitory action of digestive enzymes The form of the preparation may be tea, beverages, granules, tablets, hard capsules, and the like, and is not particularly limited. At this time, the herbal medicine is preferably contained in an amount of 30% by weight or less based on the combined weight of the two young leaves and the herbal medicine in terms of the effect. When the herbal medicine is contained in an amount exceeding the above 30% by weight, no clear effect can be obtained in the weight loss effect, which is demonstrated by the following experimental example.

본 발명의 조성물을 차로서 제조할 경우, 잘 건조된 두충엽은 통상의 배전기로 배전처리하여도 되지만, 영양성분의 손실을 최소화하고, 맛과 향의 기호성을 양호하게 하기 위하여, 원적외선 드럼 배전기로 100∼130℃에서 5∼30분 동안, 파장 10∼100㎛에서 원적외선 배전처리한다.When preparing the composition of the present invention as a tea, well-dried two-leaf lobe may be roasted by a conventional distributor, but in order to minimize loss of nutrients and to improve palatability of taste and aroma, a far-infrared drum distributor is used. Far-infrared roasting treatment is performed at a wavelength of 10 to 100 µm for 5 to 30 minutes at 100 to 130 ° C.

감잎, 산사자, 월견자, 결명자, 황금 및 동규자의 생약재의 경우에도 영양성분의 손실을 최소화하고 맛과 향의 기호성을 양호하게 하기 위하여, 각각 원적외선드럼 배전기로 80∼110℃에서 5∼30분 동안, 파장 10∼100㎛에서 원적외선 배전처리한다. 이들 생약재는 80℃미만으로 배전처리할 경우 각 원료 고유의 이미, 이취가 남아 있어 두충엽에 배합시 기호도를 저하시키며, 120℃ 이상으로 배전처리 할 경우 강향(强香)으로 인해 두충엽 고유의 향미를 소실시켜 기호도를 저하시킨다.Even in the case of persimmon leaves, hawthorn, woldogja, gwanjaja, golden and copper medicinal herbs, to minimize the loss of nutrients and to improve the palatability of taste and aroma, each far infrared drum distributor for 5-30 minutes at 80 ~ 110 ℃ Far-infrared distribution is performed at a wavelength of 10 to 100 µm. These herbal medicines retain their own odor when they are roasted at temperatures below 80 ° C, which reduces their palatability when blended into two lobes. Loss of flavor reduces the preference.

본 발명의 조성물은 상기와 같이 배전처리한 두충엽에 감잎, 산사자, 월견자, 결명자, 황금 및 동규자로 이루어진 군에서 선택된 1종 이상의 생약재를 그 배합량이 30중량% 이하가 되도록, 바람직하게는 10∼20중량%가 되도록 배합하여 함유하며, 그대로 차로 하거나 0.15∼1mm로 분쇄한 후 티백화하여 음용이 간편한 티백차로 할 수 있다.The composition of the present invention is one or more herbal medicines selected from the group consisting of persimmon leaves, hawthorn, moon dog, gwanjaja, golden and copper gyubu in roasted two-leafed leaves as described above so that the blending amount is 30% by weight or less, preferably 10 It can be blended and contained in an amount of -20% by weight, and can be used as it is or as a tea bag, which can be easily converted to tea bag after pulverizing to 0.15 to 1 mm.

또한, 본 발명의 조성물을 음료로서 제조할 경우, 두충엽과 각각의 생약재를 식용수 또는 식용 알콜로 통상의 생약재 추출방법에 의해 추출하며, 본 발명은 이들 추출방법에 의해 제한받지 않는다. 이때, 두충엽 엑기스를 조성물 전체 중량에 대해 고형분 기준으로 0.2중량%, 감잎, 산사자, 월견자, 결명자, 황금 및 동규자 엑기스중 1종 또는 2종 이상의 생약재 엑기스를 고형분 기준으로 0.02∼0.05중량%의 양으로 함유하는 것이 효과면에서 바람직하다.In addition, when the composition of the present invention is prepared as a beverage, the two leaves and each herbal medicine is extracted with drinking water or edible alcohol by a conventional herbal medicine extraction method, the present invention is not limited by these extraction methods. At this time, the two-leaf lobe extract based on the solid content of 0.2% by weight, persimmon leaf, hawthorn, moon dog, gwanjaja, gold and copper extract, one or two or more herbal extracts of 0.02 to 0.05% by weight It is preferable to contain in quantity from an effect point.

본 발명에 따른 음료는 상기한 두충엽 엑기스 및 생약재 엑기스 외에, 통상적인 음료에 첨가되는 첨가물을 함유할 수 있으며, 특별히 한정되지는 않느다. 즉, 본 발명에 따른 음료는 그외 성분으로, 올리고당, 프락토올리고당, 말토올리고당, 갈락토올리고당, 말티톨, 락티톨 등의 저칼로리 감미료와 아스파탐, 스테비아 등의 고감미 감미료 중에서 선택된 1종이상의 감미료를 더 함유할 수 있으며, 구연산, 사과산, 아스코르빈산 중에서 선택된 1종 이사의 산미료 및 비타민 B군(B1, B2, B6, B12), 니코틴산아미드, 나이아신, 각종 아미노산 등의 기카 보조성분을 함유할 수도 있다.The beverage according to the present invention may contain additives added to conventional beverages, in addition to the above-mentioned two-leaf extract and herbal extracts, but is not particularly limited. That is, the beverage according to the present invention further comprises a low-calorie sweetener such as oligosaccharide, fructooligosaccharide, malto oligosaccharide, galactooligosaccharide, maltitol, lactitol, and at least one sweetener selected from high sweetener such as aspartame and stevia. It may contain one or more acidulants selected from citric acid, malic acid, ascorbic acid, and other organic components such as vitamin B group (B1, B2, B6, B12), nicotinic acid amide, niacin, and various amino acids. .

본 발명의 조성물을 과립, 정제, 경질캡슐로 제조하는 경우에는 두충엽과 각생약재를 엑기스 건조분말로 하여 제조하되, 통상의 엑기스 동결건조법을 사용하며, 이들 방법에 의해 제한받지 않는다.When the composition of the present invention is prepared in granules, tablets, hard capsules, the cedar leaf and each herbal medicine is prepared as an extract dry powder, using a conventional extract lyophilization method, and is not limited by these methods.

본 발명의 조성물이 갖는 효능은 다음의 실험예를 통하여 입증하였다.The efficacy of the composition of the present invention was demonstrated through the following experimental example.

[실험예 1 ] α-아밀라제의 활성 저해실험Experimental Example 1 Experiment of Inhibiting Activity of α-amylase

0.02M의 초산칼슘을 첨가한 0.2M의 초산완충용액(pH5.5)에 α-아밀라제(Sigma VI - B Type)를 0.02%의 농도로 용해한 후 효소용액으로 사용한다.Dissolve α-amylase (Sigma VI-B Type) in a concentration of 0.02% in 0.2M acetic acid buffer solution (pH5.5) containing 0.02M calcium acetate and use it as an enzyme solution.

또한, 기질로는 수영성 전분을 0.1M의 초산완충용액(pH5.5)에 1.5%의 농도로 용해시켜 사용한다. 식용수로 추출한 각 생약재 추출액 0.5㎖(고형분 0.1% 기준)와 효소용액 0.5㎖와의 혼합액을 처리구로 하고, 생약재 추출액 대신 증류수를 사용하여 증류수 0.5㎖와 효소용액 0.5㎖와의 혼합액을 대조구 2(Control)으로 하며, 증류수0.5㎖와 초산완충용액 0.5㎖와의 혼합액을 대조구1(Blank)로 하며, 각 실험구를 37℃, 10분가 정치시킨 후 사용하였다.As a substrate, swimming starch is dissolved in 0.1 M acetic acid buffer solution (pH 5.5) at a concentration of 1.5% and used. 0.5 ml of each herbal extract extracted with drinking water (based on 0.1% solids) and 0.5 ml of enzyme solution were used as treatment, and the mixture of 0.5 ml of distilled water and 0.5 ml of enzyme solution was used instead of the crude herb extract. The mixed solution of 0.5 ml of distilled water and 0.5 ml of acetic acid buffer solution was used as Control 1 (Blank), and each experiment was used after standing at 37 ° C. for 10 minutes.

각각의 실험구에 기질용액을 2㎖씩 첨가하여 37℃에서 10분간 반응시키고, 0.5N의 염산과 0.5N의 초산을 1:5의 비율로 혼합한 용액을 5㎖씩 첨가하여 효소반응을 정지시킨 후 각 반응액 0.1㎖에 0.002%의 요오드(I)와 0.5%의 요오드화칼륨(KI)을 혼합한 발새액을 5㎖ 첨가하여 20분간 반응시켰다. 660nm에서 흡광도를 측정하였으며, 효소저해율은 대조구 1과 대조구 2의 흡광도의 차이에 대한 처리구와 대조구 2의 흡광도 차이의 비율로 나타내었다. 표 1에 각 생약재 추출액의 α-아밀라제의 저해율을 나타내었다.2 ml of substrate solution was added to each experimental section for 10 minutes at 37 ° C, and 5 ml of a solution containing 0.5 N hydrochloric acid and 0.5 N acetic acid at a ratio of 1: 5 was added to stop the enzymatic reaction. After the reaction, 5 ml of a mixture of 0.002% of iodine (I) and 0.5% of potassium iodide (KI) was added to 0.1 ml of each reaction solution and allowed to react for 20 minutes. The absorbance was measured at 660 nm, and the enzyme inhibition rate was expressed as the ratio of the absorbance difference between the control and control 2 to the difference in absorbance between the control 1 and the control 2. Table 1 shows the inhibition rate of α-amylase of each herbal extract.

표 1. 각 생약재의 α-아밀라제의 활성 저해율Table 1. Inhibition rate of α-amylase of each herbal

상기한 표 1에서 보는 바와 같이, 각생약재의 a-아밀라제의 활성 저해효과는 산사자, 월견자, 감잎, 황금, 동규자의 순으로 우수하였다.As shown in Table 1, the inhibitory effect of the a-amylase of each herbal medicine was excellent in the order of hawthorn, moon dog, persimmon leaf, gold, copper sequential.

[실험예 2] 리파제의 활성 저해실험Experimental Example 2 Inhibition of Lipase Activity

0.1M의 구연산 용액 9.15㎖와 0.2M의 인산수소나트륨 용액 90.85㎖를 흔합하여 제조한 McIlvian 완충용액(pH7.4)에 돼지췌장에서 추출한 리파제(sigma Type II)0.71mg/㎖의 농도로 용해한 후 이를 효소용액으로 사용한다.In a McIlvian buffer solution (pH7.4) prepared by mixing 9.15 ml of 0.1 M citric acid solution and 90.85 ml of 0.2 M sodium hydrogen phosphate solution, dissolved in a concentration of 0.71 mg / ml lipase (sigma Type II) extracted from porcine pancreas. This is used as enzyme solution.

기질로서 트리올레인(triolein) 1㎖를 시험관에 넣고, 여기에 McIlvain 완충용액 7㎖를 첨가하여 사용한다. 여기에 THF(테트라히드로푸란; Tetrahydrofuran)로 추출한 생약재 추출액을 1㎖씩 첨가하여 처리구로 한다. 상기한 기질용액에 생약재 추출액 대신 THF용액 1㎖를 가한 용액을 대조구 2(Control)로 하고, 효소액을 첨가하지 않은 완충용액을 1㎖ 가한 용액을 대조구 1(Blank)으로 하여, 자연분해되어 잔존하는 지방산을 측정하였다.As a substrate, 1 ml of triolein is placed in a test tube, and 7 ml of McIlvain buffer is added thereto. 1 ml of herbal medicine extract extracted with THF (Tetrahydrofuran) is added thereto to obtain a treatment tool. The solution obtained by adding 1 ml of THF solution to the substrate solution instead of the herbal extract was used as Control 2, and 1 ml of the buffer solution without adding the enzyme solution was used as Control 1 (Blank). Fatty acid was measured.

각각의 실험구에 미리 제조한 효소용액을 1㎖씩 첨가한 후, 37℃에서 1시간 진탕하여 반응시켰다. 에탄올 7㎖를 부어 반응을 정지시킨 후, 0.05N의 수산호나트륨으로 분해된 지방산을 적정하였다. 리파제의 저해율(%)은 대조구 1과 대조구 2의 수화나트륨액 적정 ㎖수 차이의 비율로 나타내었다. 표 2에 각 생약재의 리파제의 활성저해율을 나타내었다.1 ml of the enzyme solution prepared in advance was added to each experimental section, followed by shaking for 1 hour at 37 ° C. After 7 ml of ethanol was poured out to stop the reaction, the fatty acid decomposed with 0.05 N sodium hydroxide was titrated. Inhibition rate (%) of the lipase was expressed as the ratio of the appropriate ml number of sodium hydride solution of Control 1 and Control 2. Table 2 shows the activity inhibition rate of the lipase of each herbal medicine.

표 2. 각 생약재의 리파제의 활성 저해율Table 2. Inhibition rate of lipase activity of each herbal

상기한 표 2에서 보는 바와 같이, 각 생약재의 리파제의 활성 저해효과는 감잎, 결명자, 월견자, 산사자의 순으로 우수하였다.As shown in Table 2 above, the inhibitory effect of the lipase of each herbal medicine was excellent in the order of persimmon leaf, Cultivator, moon dog, hawthorn.

이상의 실험예1 과 실험예 2를 통하여, 본 발명의 조성물에 함유되는 생약재로서 선정된 감잎, 산사자, 월견자, 결명자, 황금 치 동규자는 인체내 소화효소인로서 a-아밀라제와 리파제의 활성 저해능력이 우수한 생약재임을 수알 수 있다.Through the above Experimental Example 1 and Experimental Example 2, persimmon leaf, hawthorn, wolseulja, Cultivator, golden larvae selected as a herbal medicine contained in the composition of the present invention is a digestive enzyme in the human body, and inhibits the activity of a-amylase and lipase It is understood that this is an excellent herbal medicine.

또한, 하기의 동물실험을 통해 이들 생약재들의 체중감량 효과, 혈중 콜레스테롤 및 혈중 중성지방(Triglyceride)저하효과를 입증하였다.In addition, the following animal experiments demonstrated the weight loss effects, blood cholesterol and triglyceride lowering effects of these herbal medicines.

[실험예 3 ] 두충엽 및 각 생약재 단독 투여시 체중변화 측정 동물실험 두충엽을 통상의 방법으로 물로 추출한 후 고형분 10%가 될 때까지 농축하여 두충염 엑기스를 제조하였다. 또한 감잎, 산사자, 월견자, 결명자, 황금 및 동규자도 같은 방법으로 물로 추출한 후 고형분 10%가 되도록 농축하여 각각의 엑기스를 제조하였다.[Experimental Example 3] Measurement of body weight change when administering both larvae and each medicinal herb Animal experiments After extracting the larvae with water in a conventional manner, and concentrated to 10% solids to prepare a chungchung salt extract. In addition, persimmon leaves, mountain lions, moon dogs, crystals, golden and Donggyuja were also extracted with water in the same manner and concentrated to 10% solids to prepare each extract.

실험동물로서 4주령의 수커 SD(Sqrague-Dawoey)랫트를 물과 일반사료를 10일간 자유 섭위시켜 순응기간을 마친 후, 실험군 당 6마리씨 철망케이지에 담아 평균 체중이 200±5g이 되도록 조절하였다. 이때부터 사료에 우지(동물성 유지) 0.5%, 콩기름(식물성 유지) 0.5%를 혼합하여 투여하기 시작하였으며, 유지 함유사료만을 먹이는 대조군을 따로 마련하고, 실험군별로 두충엽 엑기스 및 각 생약재 엑기흐를 1일 1회 200mg/체중kg 경구투여하였다.As experimental animals, four-week-old Sucker Rada (Sqrague-Dawoey) rats were freely fed with water and normal feed for 10 days to complete the acclimatization period, and then placed in 6 wire mesh cages per experimental group to adjust their average weight to 200 ± 5g. . From this time, 0.5% of Uji (animal oil) and 0.5% of soybean oil (vegetable oil) were mixed and administered to the feed, and a control group to feed only oil-containing feed was prepared separately. One dose of 200 mg / kg body weight was administered orally.

실험군 1 : 두충엽 엑기스를 200mg/체중kg 경구투여Experimental group 1: oral administration of cedar leaf extract 200mg / weight kg

실험군 2 : 감잎 엑기스를 200mg/체중kg 경구투여Experimental group 2: oral administration of persimmon leaf extract 200mg / weight kg

실험군 3 : 산사자 엑기스를 200mg/체중kg 경구투여Experimental group 3: oral administration of hawthorn extract 200mg / weight kg

실험군 4 : 월견자 엑기스를 200mg/체중kg 경구투여Experimental group 4: 200 mg / weight kg oral administration of moon dog extract

실험군 5 : 결명자 엑기스를 200mg/체중kg 경구투여Experimental group 5: 200 mg / kg body weight oral administration

실험군 6 : 황금 엑기스를 200mg/체중kg 경구투여Experimental group 6: oral administration of golden extract 200mg / weight kg

실험군 7 : 동규자 엑기스를 200mg/체중kg 경구투여Experimental group 7: oral administration of Donggyuja extract 200 mg / weight kg

2주 경과시마다 디지탈 저울로 체중을 측정하여, 각군 체중의 평균값을 구하였으며 하기의 표 3에 그 결과를 나타내었다.After 2 weeks, the weight was measured using a digital scale, and the average value of the weight of each group was obtained, and the results are shown in Table 3 below.

표 3. 두충엽 엑기스 및 각 생약재 엑기스 투여에 따른 체중변화Table 3. Changes in body weight according to the administration of cedar leaf extract and each herbal extract

상기한 표 3에서 보는 바와 같이, 두충엽 엑기스와 각 생야재 엑기스를 동일한 양으로 랫트에 투여하였을때 체중감량 효과는 두충엽 엑기스 투여군이 가장 우수한 것으로 나타났다.As shown in Table 3 above, the weight loss effect of the two leaf lobe extract and each wild vegetable extract in the rats in the same amount was found to be the most excellent.

따라서, 본 발명자들은 두충엽을 주원료로 함유하고, 여기에 1종 이상의 생약재를 더 함유하였을때의 체중감량 효과의 상승된 효과를 하기의 실험예 4의 동물실험을 통하여 측정하였다.Therefore, the present inventors measured the increased effect of the weight loss effect when the two main lobe containing as a main ingredient, and further contains one or more herbal medicines through the animal experiment of Experimental Example 4 below.

[실험예 4 ] 두충엽과 각 생약재 혼합 투여시의 체중변화 측정 동물실험 두충엽 엑기스에 생약재 엑기스를 첨가, 혼합하였을때의 체중감량 효과를 측정하기 위해 실험예 3의 고형분 10%의 두충엽 엑기스와 고형분 10%의 각 생약재 엑기스를 9:1의 비율로 혼합하여 하기 실험군별로 제조하였다.[Experimental Example 4] Measurement of the weight change during the administration of the mixture of the two loaves and each herbal medicine To measure the weight loss effect of adding the herbal medicine extract to the two-leaf extract of the animal extract and mixed, the two-leaf extract of 10% solids of Experimental Example 3 Each herbal extract with a solid content of 10% was mixed at a ratio of 9: 1 to prepare the following experimental groups.

실험동물로서 4주령의 수컷 SD 랫트를 물과 일반사료를 10일간 자유섭취시켜 순응기간을 마친 후 실험군당 6마리씩 철망케이지에 담아 평균체중이 200±5g이되도록 조절하였다. 이때부터 사료에 우지(동물성 유지)0.5%, 콩기름(식물성 유지)0.5%를 혼합하여 투여하기 시작하였으며, 유지함유 사료만을 먹이는 대조군을 따로 마련하고, 실험군별로 두충엽 단독 및 두충엽과 각 생약재 엑기스를 혼합하여 1일 1회 200mg/체중kg 경구 투여하였다.As the experimental animals, male SD rats of 4 weeks old were freely ingested with water and general feed for 10 days, and after completion of the acclimation period, 6 animals per experimental group were placed in a wire cage to adjust the average weight to 200 ± 5g. From this time, Uji (animal oil) 0.5% and soybean oil (vegetable oil) 0.5% were mixed and administered to the feed, and a control group to feed only the oil-containing feed was prepared separately. The mixture was administered orally once a day 200 mg / kg body weight.

실험군 1 : 두충엽 엑기스를 200mg/체중kg 경구투여Experimental group 1: oral administration of cedar leaf extract 200mg / weight kg

실험군 2 : 두충엽 엑기스 + 감잎 엑기스(9:1) 200mg/체중kg 경구투여Experimental group 2: two leaf lobe extract + persimmon leaf extract (9: 1) 200mg / weight kg oral administration

실험군 3 : 두충엽 엑기스 + 산사자 엑기스(9:1) 200mg/체중kg 경구투여Experimental group 3: two leaf lobe extract + mountain lion extract (9: 1) 200mg / weight kg oral administration

실험군 4 : 두충엽 엑기스 + 월견자 엑기스(9:1) 200mg/체중kg 경구투여Experimental group 4: two leaf lobe extract + moon dog extract (9: 1) 200mg / weight kg oral administration

실험군 5 : 두충엽 엑기스 + 결명자 엑기스(9:1) 200mg/체중kg 경구투여Experimental group 5: two leaf lobe extract + deficiency extract (9: 1) 200mg / weight kg oral administration

실험군 6 : 두충엽 엑기스 + 황금 엑기스(9:1) 200mg/체중kg 경구투여Experimental group 6: two leaf lobe extract + golden extract (9: 1) 200mg / weight kg oral administration

실험군 7 : 두충엽 엑기스 + 동규자 엑기스(9:1) 200mg/체중kg 경구투여Experimental group 7: two leaf lobe extract + Donggyuja extract (9: 1) 200mg / weight kg oral administration

2주 경과시마다 디지탈 저울로 체중을 축정하여, 각군 체중의 평균값을 구하였으며, 하기의 표 4에 그 결과를 나타내었다.The weight of each group was measured by the digital scale every two weeks, and the average value of the weight of each group was obtained, and the results are shown in Table 4 below.

표 4. 두충엽 엑기스 및 생약재 엑기스 혼합 투여에 따른 체중변화Table 4. Changes in body weight according to the mixed administration of cedar leaf extract and herbal extract

상기한 표 4에서 보는 바와같이, 두충엽 엑기스를 단독 투여한 실험군 1보다 두충엽 엑기스에 각 생약재를 첨가 혼합하여 투여한 실험군2∼7에서 모두 월동한 체중감량의 상승효과를 나타내었으며, 이는 두충엽에 소화효소 활성 저해효과를 갖는 생약재를 배합하여 함유함으로써, 더욱 상승된 체중감량 효과를 부여할 수 있음을 입증한 것이다.As shown in Table 4 above, in the experimental groups 2 to 7 administered by adding and mixing each herbal medicine to the two larvae extract than the experimental group 1 administered the two larvae extract alone showed a synergistic effect of weight loss over winter It is proved that by combining and containing a herbal medicine having an inhibitory effect on digestive enzyme activity in the leaves, it is possible to give an even higher weight loss effect.

하기의 실험예 5는 두충엽과 생약재의 혼합비에 따른 체중감량 효과를 동물실험을 통해 검색하여, 본 발명의 두충엽과 생약재의 혼합비를 경정한 것이다.Experimental Example 5 below is to search the weight loss effect according to the mixing ratio of the two lobe and the herbal medicine through an animal experiment, to determine the mixing ratio of the two lobe and herbal medicine of the present invention.

[실험예 5 ] 두충엽과 생약재의 혼합비 결정 동물실험Experimental Example 5 Mixing Ratio Determination of Tobacco Leaf and Herbal Medicine

두충엽을 통상의 방법으로 물로 추출한 후 고형분 10%가 될 때까지 농축하여 두충엽 엑기스를 제조하였다.The cedar leaf extract was extracted with water by a conventional method, and concentrated to 10% solids to prepare a cedar leaf extract.

또한 감잎, 신사자, 월견자, 결명자, 황금 및 동규자를 같은 중량비로 혼합하여 통상의 방법으로 물 추출한 후 고형분 10%가 되도록 농축하여 혼합 엑기스를 제조하였다.In addition, persimmon leaf, gentleman, moon dog, crystallization, golden and Donggyugwa were mixed in the same weight ratio, water was extracted by a conventional method, and then concentrated to 10% solids to prepare a mixed extract.

실험동물로서 4주령의 수컷 SD랫트를 물과 일반사료를 10일간 자유섭취시켜 순응기간을 마친 후 실험군당 6마리씩 철망케이지에 담아 평균체중이 200±5g이 되도록 조절하였다. 이때부터 사료에 우지(동물성 유지) 0.5%, 콩기름(식물성 유지) 0.5%를 혼합하여 투여하기 시작하였으며, 유지 함유 사료만을 먹이는 대조군을 따로 마련하고, 실험군별로 두충엽 엑기스와 생약재혼합 엑기스를 혼합하여 1일 1회 200mg/체중kg 경구 투여하였다.As the experimental animals, male SD rats of 4 weeks old were freely ingested with water and general feed for 10 days, and after completion of the acclimation period, 6 rats per experimental group were placed in a wire cage to adjust the average weight to 200 ± 5g. At this time, 0.5% of Uji (animal oil) and 0.5% of soybean oil (vegetable oil) were mixed and administered to the feed, and a control group to feed only oil-containing feed was prepared separately. 200 mg / kg body weight was administered orally once daily.

실험군 1 : 두충엽 엑기스 + 생약재혼합 엑기스(9:1) 200mg/체중kg 경구투여Experimental group 1: two leaf lobe extract + herbal medicine mixed extract (9: 1) 200mg / weight kg oral administration

실험군 2 : 두충엽 엑기스 + 생약재혼합 엑기스(8:2) 200mg/체중kg 경구투여Experimental group 2: two leaf lobe extract + herbal medicine mixed extract (8: 2) 200mg / weight kg oral administration

실험군 3 : 두충엽 엑기스 + 생약재혼합 엑기스(7:3) 200mg/체중kg 경구투여Experimental group 3: two leaf lobe extract + herbal medicine mixed extract (7: 3) 200mg / weight kg oral administration

실험군 4 : 두충엽 엑기스 + 생약재혼합 엑기스(6:4) 200mg/체중kg 경구투여Experimental group 4: two leaf lobe extract + herbal medicine mixed extract (6: 4) 200mg / weight kg oral administration

실험군 5 : 두충엽 엑기스 + 생약재혼합 엑기스(5:5) 200mg/체중kg 경구투여Experimental group 5: two leaf lobe extract + herbal medicine mixed extract (5: 5) 200mg / weight kg oral administration

실험군 6 : 두충엽 엑기스 + 생약재혼합 엑기스(4:6) 200mg/체중kg 경구투여Experimental group 6: two leaf lobe extract + herbal medicine mixed extract (4: 6) 200mg / weight kg oral administration

2주 경과시마다 디지탈 저울로 체중을 측정하여, 각군 체중의 평균값을 구하였으며, 하기의 표 5에 그 결과를 나타내었다.The weight of each group was measured with a digital balance every two weeks, and the average value of each group's weight was calculated. The results are shown in Table 5 below.

표 5. 두충엽 엑기스 + 생약재혼합 엑기스의 배합비에 따른 각 실험군의 체중변화Table 5. Changes in weight of each experimental group according to the mixing ratio of the two leaf extracts and herbal remix extract

상기 표 5에서는 보는 바와 같이, 두충엽 엑기스와 생약재혼합 엑기스의 혼합비에 따른 체중감량 효과에 있어서, 생약재 엑기스의 함량이 전체 투여량의 30중량%를 넘는 경우(실험군 4, 5, 6)에는 뚜렷한 효과를 보이지 않는 것을 알 수 있다. 따라서, 두충엽에 첨가하는 생약재의 함량은 30중량% 이하로 하는 것이 바람직하다.As shown in Table 5, in the weight loss effect according to the mixing ratio of the two leaf extract and the herbal medicine mixture extract, when the content of the herbal medicine extract exceeds 30% by weight of the total dose (experimental group 4, 5, 6) It can be seen that there is no effect. Therefore, the content of the herbal medicines added to the two leaves is preferably 30% by weight or less.

[실험예 6] 혈중 총콜레스테롤 측정 동물실험 실험동물로서 4주령의 수컷 SD랫트를 물과 일반사료를 10일간 자유 섭취시켜 순응기간을 마친 후, 실험군 당 6마리씩 철망케이지에 담아 평균 체중이 200±5g이 되도록 조절하였다. 이때부터 사료에 콜레스테롤을 1% 혼합하여 투여하기 시작하였으며, 1%의 콜레스테롤 함유 사료만을 먹이는 대조군을 따로 마련하고, 1% 콜레스테롤 함유 사료만을 먹이는 대조군을 따로 마련하고, 1% 콜레스테롤 함유 사료에 두충엽 엑기스 건조분말 단독 또는 두충엽과 각 생약재 엑기스의 건조분말을 혼합, 첨가한 다음과 같은 실험군을 마련하였다.Experimental Example 6 Measurement of Total Cholesterol in Blood Animal Experimental Animal SD rats of 4 weeks of age were ingested freely with water and general feed for 10 days, and after completion of the acclimation period, 6 animals per group were placed in a wire cage and the average weight was 200 ±. Adjusted to 5 g. At this time, the mixture was administered with 1% of cholesterol in the feed, and a control group was fed to feed only 1% cholesterol, and a control group was fed to feed only 1% cholesterol, and 2% to 2% cholesterol-containing feed. The following experimental group was prepared by mixing and adding the extract dry powder alone or the two young leaves and the dry powder of each herbal extract.

실험군 1 : 두충엽 엑기스 건조분말 0.3%Experimental group 1: two leaf extract extract powder 0.3%

실험군 2 : 두충엽 엑기스 건조분말 0.25% + 감잎 엑기스 건조분말 0.05%Experimental Group 2: Two leaf extract extract powder 0.25% + persimmon leaf extract powder 0.05%

실험군 3 : 두충엽 엑기스 건조분말 0.25% + 산사자 엑기스 건조분말 0.05%Experimental group 3: two leaf extract extract powder 0.25% + mountain lion extract dry powder 0.05%

실험군 4 : 두충엽 엑기스 건조분말 0.25% + 월견자 엑기스 건조분말 0.05%Experimental group 4: two-leaf extract extract powder 0.25% + moon dog extract dry powder 0.05%

실험군 5 : 두충엽 엑기스 건조분말 0.25% + 결명자 엑기스 건조분말 0.05%Experimental group 5: two leaf extract extract powder 0.25% + deficiency extract dry powder 0.05%

실험군 6 : 두충엽 엑기스 건조분말 0.25% + 황금 엑기스 건조분말 0.05%Experimental Group 6: Two leaf extract powder 0.25% + golden extract dry powder 0.05%

실험군 7 : 두충엽 엑기스 건조분말 0.25% + 동규자 엑기스 건조분말 0.05%Experimental group 7: two leaf extract extract powder 0.25% + Donggyuja extract dry powder 0.05%

상기 실험군 별로 사료를 투여하여 랫트를 사육시킨 다음, 2주와 4주 경과 후 꼬리 정맥에서 혈액을 채취하되 채혈전 12시간 동안 금식을 시켰다. 혈액을 3000rpm으로 15분간 원심분리하여 혈청을 얻은 후, 혈청중 총콜레스테롤 양은 효소적 방법을 이용한 시그마사(Singna社)의 진단키트(No. 352)를 사용하여 측정하였다. 표 6에 각 실험군의 혈청 총콜레스테롤 양(mg/dl)을 비교하였으며, 대조군에 비교한 실험군의 총콜레스테롤 농도 저하율(5)을 나타내었다.Rats were reared by feeding the experimental groups, and blood was collected from the tail vein after 2 and 4 weeks, but fasted for 12 hours before blood collection. After serum was obtained by centrifuging the blood at 3000 rpm for 15 minutes, the total cholesterol content in the serum was measured using a diagnostic kit (No. 352) from Sigma (Singna) using an enzymatic method. In Table 6, the total serum cholesterol level (mg / dl) of each experimental group was compared, and the total cholesterol concentration drop rate (5) of the experimental group compared to the control group was shown.

표 6. 각 실험군의 혈청 총 콜레스테롤 농도 비교Table 6. Comparison of Serum Total Cholesterol Concentration in Each Experimental Group

[실험예 7] 혈중 중성지방(Triglyceride)측정 동물실험Experimental Example 7 Triglyceride Measurement Animal Test

실험동물로서 4주령의 수컷 SD랫트를 물과 일반사료를 10일간 자유섭취시켜 순응기간을 마친 후, 실험군 당 6마리씩 철망케이지에 담아 평군 체중이 200±5g이 되도록 조절하였다. 이때부터 사료에 우지(동물성 유지) 0.5%, 콩기름(식물성 유지) 0.5%를 혼합하여 투여하기 시작하였으며, 유지 함유 사료만을 먹이는 대조군을 따로 마련하고, 유지 함유 사료에 두충엽 엑기스 건조분말 단독 또는 두충엽과 각 생약재 엑기스의 건조분말을 혼합, 첨가한 다음과 같은 실험군을 마련하였다.As a test animal, male SD rats of 4 weeks of age were freely ingested with water and general feed for 10 days to complete the acclimatization period. Then, 6 rats per experimental group were placed in a wire cage to adjust the average body weight to 200 ± 5g. At this time, 0.5% Uji (animal fat) and 0.5% soybean oil (vegetable fat) were mixed and administered to the feed, and a control group for feeding only fat-containing feed was prepared separately. The following experimental group was prepared by mixing and adding the leaves and the dry powder of each herbal extract.

실험군 1 : 두충엽 엑기스 건조분말 0.3%Experimental group 1: two leaf extract extract powder 0.3%

실험군 2 : 두충엽 엑기스 건조분말 0.25% + 감잎 엑기스 건조분말 0.05%Experimental Group 2: Two leaf extract extract powder 0.25% + persimmon leaf extract powder 0.05%

실험군 3 : 두충엽 엑기스 건조분말 0.25% + 산사자 엑기스 건조분말 0.05%Experimental group 3: two leaf extract extract powder 0.25% + mountain lion extract dry powder 0.05%

실험군 4 : 두충엽 엑기스 건조분말 0.25% + 월견자 엑기스 건조분말 0.05%Experimental group 4: two-leaf extract extract powder 0.25% + moon dog extract dry powder 0.05%

실험군 5 : 두충엽 엑기스 건조분말 0.25% + 결명자 엑기스 건조분말 0.05%Experimental group 5: two leaf extract extract powder 0.25% + deficiency extract dry powder 0.05%

실험군 6 : 두충엽 엑기스 건조분말 0.25% + 황금 엑기스 건조분말 0.05%Experimental Group 6: Two leaf extract powder 0.25% + golden extract dry powder 0.05%

실험군 7 : 두충엽 엑기스 건조분말 0.25% + 동규자 엑기스 건조분말 0.05%Experimental group 7: two leaf extract extract powder 0.25% + Donggyuja extract dry powder 0.05%

상기 실험군 별로 사료를 투여하여 랫트를 사육시킨 다음, 2주와 4주 경과후 꼬리 정맥에서 혈액을 채취하되 채혈전 12시간 동안 금식을 기켰다. 혈액을 3000rpm으로 15분간 원심분리하여 혈청을 얻은 후, 혈청중 지질 양은 시그마사(Singma社)의 진단키트(No. 337-B)를 사용하여 정량하였다. 즉, 효소적 반응에 의해 생성된 퀴논이민(Quinoneimine)을 540nm에서 흡광도를 측정하여 혈청 중성지방(트리글리세리드)의 양을 측정하였다. 표 7에서 각 실험군의 형청 지방의 양(mg/dl)을 비교하였으며, 대조군에 비교한 실험군의 혈청 지방 농도 저하율(%)을 나타내었다.Rats were reared by feeding the experimental groups, and blood was collected from the tail vein after 2 and 4 weeks, but fasted for 12 hours before blood collection. After serum was obtained by centrifuging the blood at 3000 rpm for 15 minutes, the amount of lipid in the serum was quantified using a diagnostic kit (No. 337-B) from Sigma. That is, the amount of serum triglyceride (triglyceride) was measured by measuring the absorbance of quinoneimine produced by the enzymatic reaction at 540 nm. In Table 7, the amount of sperm fat of each experimental group (mg / dl) was compared, and the percentage of decrease in serum fat concentration of the experimental group compared to the control group was shown.

표 7. 각 실험군의 혈청 중성지방(Triglyceride)농도 비교Table 7. Comparison of Serum Triglyceride Concentration in Each Experimental Group

상기한 실험예 6과 실험예 7의 동물실험 결과에서 보여지는 바와 같이, 두충엽에 소화효소 저해효소가 있는 감잎, 산사자, 월견자, 결명자, 황금, 동규자 등을 첨가하여 투여할 경우 제중감량 효과는 물론 혈중 콜레스테롤과 중성지방의 양이 두충엽 단독 투여에 비해 월등한 상승효과를 보임이 입증되었다.As shown in the results of the animal experiments of Experimental Example 6 and Experimental Example 7, weight-loss effect when administered by adding persimmon leaf, hawthorn, moon dog, deficiency, golden, Donggyuja, etc. Of course, the amount of cholesterol and triglycerides in the blood was proved to be superior to the administration of cedar lobe alone.

따라서, 두충엽을 주원료로 함유하고, 여기에 감잎, 산사자, 월견자, 결명자, 황금 및 동규자 중에서 선택된 1종 이상의 생약재를 더 함유함을 특징으로 하는 본 발명에 따른 건강식품 조성물은 우수한 체중감량 효과 뿐만 아니라, 혈중 콜레스테롤 농도 및 중성지방의 농도를 현저히 저하시켜 비만에 의해 유발되는 동맥경화, 고혈압 등의 성인병 예방 효과도 부여할 수 있다.Therefore, the health food composition according to the present invention is characterized by containing the two leaf lobes as the main raw material, and further contains at least one herbal medicine selected from persimmon leaf, mountain lion, moon dog, gyeolja, golden and Donggyuja In addition, by lowering the concentration of cholesterol and triglycerides in the blood significantly, it can also impart an adult disease prevention effect such as arteriosclerosis and hypertension caused by obesity.

이하, 본 발명의 실시예를 들어 더욱 상세하게 본 발명을 설명한다. 본 발명은 이들 실시예에만 한정되지는 않는다.Hereinafter, the present invention will be described in more detail with reference to examples of the present invention. The present invention is not limited only to these examples.

[실시예 1]Example 1

잘 건조된 두충엽을 원적외선 드럼 배전기로 110℃에서 30분 동안, 파장 30㎛에서 우너적외선 배전처리하였다. 또, 감잎, 산사자, 월견자, 결명자, 황금, 동규자 등의 생약재를 80℃에서 30분 동안, 파장 30㎛에서 원적외선 배전처리하였다.The well-dried two-leaf lobe was subjected to uninfrared ray roasting at a wavelength of 30 μm for 30 minutes at 110 ° C. with a far-infrared drum distributor. In addition, herbal medicines such as persimmon leaves, hawthorn, moon dogs, crystals, gold, and Donggyuja were far-infrared roasted at 30 占 폚 for 30 minutes at 80 占 폚.

배전처리한 두충엽 및 각 생약재를 절단기를 이용하여 0.15∼2mm로 분쇄하였다.The roasted cedar leaf and each herbal medicine were ground to 0.15-2 mm using a cutter.

[실시예 2]Example 2

실시예 1에서 제조한 두충엽과 감잎, 산사자, 월견자를 7:1:1:1의 비율로 혼합하여 차로 하였다.The cedar leaf, persimmon leaf, hawthorn, and moon dog, which were prepared in Example 1, were mixed at a ratio of 7: 1: 1: 1 to obtain tea.

[실시예 3]Example 3

실시예 1에서 제조한 두충엽과 결명자, 황금, 동규자를 7:1:1:1의 비율로 혼합하여 차로 하였다.Tofu was prepared in Example 1 was mixed with the two leaves, the crystallization, the golden, copper qualities in the ratio of 7: 1: 1: 1.

[실시예 4]Example 4

실시예 1에서 제조한 두충엽과 감잎, 산사자, 결명자를 7:1:1:1의 비율로 혼합하여 1.5∼2g 티백화하였다.The cedar leaf, persimmon leaf, hawthorn, and Cultivator prepared in Example 1 were mixed in a ratio of 7: 1: 1: 1 to 1.5-2 g teabags.

[실시예 5]Example 5

실시예 1에서 제조한 두충엽과 산사자, 결명자, 동규자를 7:1:1:1의 비율로 혼합하여 1.5∼2g 티백화하였다.The cedar leaf, hawthorn, hawthorn, and sperm prepared in Example 1 were mixed at a ratio of 7: 1: 1: 1 to 1.5-2 g teabags.

[실시예 6]Example 6

두충엽, 감잎, 산사자, 월견자, 결명자, 황금, 동규자 각 1kg씩에 정제수 10kg을 가한 후, 80℃에서 8시간씩 3회 추출하였다. 3회 추출액을 합친 후 400메쉬로 여과하고 감압, 농축하여 고형분 60%의 각 엑기스를 얻었다.After adding 10 kg of purified water to 1 kg each of the head, leaf, persimmon leaf, mountain lion, moon dog, gwanjaja, golden, Donggyuja, extracted three times at 80 ℃ for 8 hours. The extracts were combined three times, filtered through 400 mesh, depressurized and concentrated to obtain each extract having a solid content of 60%.

[실시예 7]Example 7

실시예 6에서 제조된 두충엽 엑기스를 조성물 총 중량에 대해 0.2중량%와, 감잎 엑기스, 결명자 엑기스, 동규자 엑시를 각각 0.02중량%, 0.02중량%, 0.01중량%씩을 가하여 혼합하였다. 여기에 말토올리고당 8중량%, 구연산 0.12중량%, 스테비오사이드 0.003중량%를 넣은 후, 소량의 비타민B1, B2, B3의 니코틴산 아미드 등을 첨가하고 정제수를 넣어 음료로서 제조하였다.The two-leaf lobe extract prepared in Example 6 was mixed by adding 0.2% by weight, persimmon leaf extract, Cultivator extract, and sperm extract in 0.02% by weight, 0.02% by weight, and 0.01% by weight, respectively. After adding 8% by weight maltooligosaccharide, 0.12% by weight citric acid and 0.003% by weight stevioside, a small amount of vitamin B 1 , B 2 , B 3 nicotinic acid amide and the like were added thereto, and purified water was added as a beverage.

[실시예 8]Example 8

실시예 7과 동일하게 실시하되, 생약재중 산사자 엑기스, 월견자 엑기스, 황금엑기스를 각각 0.02중량%, 0.02중량%, 0.01중량%를 첨가하여 음료로서 제조하였다.The same procedure as in Example 7 was carried out, except that 0.02% by weight, 0.02% by weight, and 0.01% by weight, respectively, were prepared as beverages.

실시예 9]Example 9

실시예 7과 동일하게 실시하되, 생약재중 감잎 엑기스, 산사자 엑기스, 월견자 엑기스, 결명자 엑기스를 0.01중량%씩 첨가하여 음료로서 제조하였다.It was carried out in the same manner as in Example 7, but was prepared as a beverage by adding 0.01% by weight of persimmon leaf extract, hawthorn extract, moon dog extract, gyeoljaja extract in herbal medicine.

[실시예 10]Example 10

실시예 7과 동일하게 실시하되, 생약재중 감잎 엑기스, 산사자 엑기스, 황금 엑기스, 동규자 엑기스를 0.01중량%씩 첨가하여 음료로서 제조하였다.It was carried out in the same manner as in Example 7, but was prepared as a beverage by adding 0.01% by weight of persimmon leaf extract, mountain lion extract, golden extract, Donggyuja extract in herbal medicine.

[실시예 11]Example 11

실시예 6에서 제조한 두충엽 및 각 생약재 엑기스를 엑기스와 결정셀로로오스의 배합비가 10:2가 되도록 하여 -20∼-30℃로 급속 동결시켰다. 이렇게 동결된 두충엽 및 각 생약재 엑기스를 동결건조기에 이송하여 0.5∼0.05mmHg의 감압을 걸고 콘덴서(Condenser)를 -50℃ 이하로 유지시켜 주면서 수분이 5% 이하가 될때까지 동결건조시켰다.The two larvae and each herbal extract prepared in Example 6 were rapidly frozen at -20 to -30 ° C so that the blending ratio of the extract and the crystal cellulose was 10: 2. The frozen two leaf lobe and each herbal extract was transferred to a freeze dryer, and subjected to freeze-drying until the water content was 5% or less while applying a reduced pressure of 0.5 to 0.05 mmHg and keeping the condenser at -50 ° C or less.

이 건조물을 냉각수가 순환되는 마쇄기(Micro pulverizer)로 마쇄하여 입도 0.04∼0.3mm크기의 두충엽과 생약재 엑기스 건조분말을 얻었다.The dried product was ground by a micropulverizer in which cooling water was circulated to obtain a dry leaf powder and a medicinal herb extract having a particle size of 0.04-0.3 mm.

[실시예 12]Example 12

실시예 11에서 제조한 두충엽 엑기스 건조분말 7kg과 감잎 엑기스 건조분말1kg, 산사자 엑기스 건조분말 1kg, 월견자 엑기스 건조분말 1kg을 고속회전 혼합기에 넣고 혼합시켰다. 여기에 멸균 정제수 3.5kg을 가여하여 다시 혼합시켜 지경 1∼2mm의 과립으로 성형하였다. 성형된 과립을 40∼50℃의 진공건조기에서 건조시킨 후, 12∼14메쉬를 통과시켜 균일한 과립으로서 제조함다.7 kg of the two-leaf extract extract powder prepared in Example 11, 1 kg persimmon leaf extract powder, 1 kg of mountain lion extract dry powder, 1 kg moon dog extract dry powder was put into a high speed rotary mixer and mixed. 3.5 kg of sterile purified water was added thereto and mixed again to form granules having a diameter of 1 to 2 mm. The molded granules are dried in a vacuum dryer at 40 to 50 ° C., and then passed through 12 to 14 mesh to prepare uniform granules.

[실시예 13]Example 13

실시예 12와 동일하게 실시하되, 생약재중 감잎 엑기스 건조분말 1kg, 결명자 엑기스 건조분말 1kg, 황금 엑기스 건조분말 0.5kg, 동규자 엑기스 건조분말 0.5kg을 혼합하여 과립으로서 제조하였다.In the same manner as in Example 12, 1kg persimmon leaf extract dry powder, 1kg gyeongja extract dry powder, 0.5kg golden extract dry powder, 0.5kg Dongguja extract dry powder was prepared as granules.

[실시예 14]Example 14

실시예 12와 동일하게 실시하되, 생약재중 월견자 엑기스 건조분말 1kg, 산사자 엑기스 건조분말 1kg, 결명자 엑기스 건조분말 0.5kg, 동규자 엑기스 건조분말 0.5kg을 혼합하여 과립으로서 제조하였다.In the same manner as in Example 12, 1kg of walnut extract extract powder, 1 kg of hawthorn extract dry powder, 0.5kg extract ginseng extract powder 0.5kg, 0.5kg Dongjaja extract dry powder was prepared as granules.

[실시예 15]Example 15

실시예 11에서 제조한 두충엽 엑기스 건조분말 7kg 과 생약재중 감잎 엑기스 건조분말 1kg, 결명자 엑기스 건조분말 1kg, 동규자 엑기스 건조분말 1kg을 고속 회전 혼합기에 넣고 혼합시켰다. 여기에 멸균 정제수 3.5kg을 가하여 다시 혼합시켜 직경 1∼2mm의 과립으로 성형하였다. 성형된 과립을 40∼50℃의 진공 건조기에서 건조시킨 후, 적당량씩 압축 성형하여 정제로서 제조하였다.7 kg of the two-leaf extract extract powder prepared in Example 11 and 1 kg of persimmon leaf extract powder, herbal extract extract powder 1kg, Dongjak extract extract powder 1kg in herbal medicine was mixed in a high speed rotary mixer. 3.5 kg of sterile purified water was added thereto and mixed again to form granules having a diameter of 1 to 2 mm. The molded granules were dried in a vacuum dryer at 40 to 50 ° C., and then compression molded in appropriate amounts to prepare tablets.

[실시예 16]Example 16

실시예 15와 동일하게 실시하되, 생약재중 월견자 엑기스 건조분말 1kg, 결명자 엑기스 건조분말 1kg,황금 엑기스 건조분말 0.5kg, 동규자 엑기스 건조분말 0.5kg을 혼합하여 정제로서 제조하였다.In the same manner as in Example 15, 1kg of geunja extract dry powder, geunja extract dry powder, 1kg of golden extract dry powder, 0.5kg of golden extract powder dry powder 0.5kg, was prepared as a tablet.

[실시예 17]Example 17

실시예 15와 동일하게 실시하되, 생약재중 감잎 엑기스 건조분말 1kg, 산사자 엑기스 건조분말 1kg,월견자 엑기스 건조분말 0.5kg, 결명자 엑기스 건조분말 0.5kg을 혼합하여 정제로서 제조하였다.In the same manner as in Example 15, 1kg persimmon leaf extract dry powder, hawthorn extract dry powder 1kg, moon dog extract dry powder 0.5kg, 0.5kg extract geunja extract dry powder was prepared as a tablet.

[실시예 18]Example 18

실시예 11에서 제조한 두충엽 엑기스 건조분말 7kg 과 생약재중 감잎 엑기스 건조분말 1kg, 월견자 엑기스 건조분말 1kg, 결명자 엑기스 건조분말 1kg을 고속 회전 혼합기에 넣고 혼합시켰다. 여기에 멸균 정제수 3.5kg을 가하여 다시 혼합시켜 직경 0.5∼ 1mm의 과립으로 성형하였다. 성형된 과립을 40∼50℃의 진공 건조기에서 건조시키고, 14∼16메쉬를 통과시켜 균일하게 한 다음, 빈 경질캡술에 충전시켜 경질캡슐로서 제조하였다.7 kg of the two-leaf extract extract powder prepared in Example 11 and 1 kg of persimmon leaf extract powder, 1 kg of moon dog extract dry powder, 1 kg deflector extract dry powder in the herbal medicine was mixed in a high speed rotary mixer. 3.5 kg of sterile purified water was added thereto and mixed again to form granules having a diameter of 0.5 to 1 mm. The molded granules were dried in a vacuum dryer at 40 to 50 ° C., homogenized by passing through 14 to 16 mesh, and then filled into empty hard capsules to prepare as hard capsules.

[실시예 19]Example 19

실시예 18과 동일하게 실시하되, 생약재중 월견자 엑기스 건조분말 1kg, 황금 엑기스 건조분말 1kg, 동규자 엑기스 건조분말 1kg을 혼합하여 경질캡슐로서 제조하였다.In the same manner as in Example 18, 1kg of golden dog extract dry powder, golden extract dry powder 1kg, 1kg of copper gyuja extract dry powder was prepared as a hard capsule.

[실시예 20]Example 20

실시예 18과 동일하게 실시하되, 생약재중 감잎 엑기스 건조분말 1kg, 산사자 엑기스 건조분말 1kg, 동규자 엑기스 건조분말 1kg을 혼합하여 경질캡슐로서 제조하였다.In the same manner as in Example 18, 1kg persimmon leaf extract dry powder, hawthorn extract dry powder, 1kg Dongjaja extract dry powder of the herbal medicine was prepared as a hard capsule.

[실험예 8] 체중 감량 효과 동물실험Experimental Example 8 Weight Loss Effect Animal Experiment

실험동물로서 4주령의 수컷 SD랫트를 물과 일반사료를 10일간 자유섭취시켜 순응기간을 마친 후 실험군당 6마리씩 철망케이지에 담아 평균체중이 200±5g이 되도록 조절하였다. 이때부터 사료에 우지(동물성 유지) 0.5%, 콩기름(식물성 유지) 0.5%를 혼합하여 투여하기 시작하였으며, 유지 함유 사료만을 먹이는 대조군을 따로 마련하고, 실험군별로 실시예 6에서 얻은 두충엽 엑기스 및 생약재 엑기스의 조성을 다양하게 하여, 혼합하여 1일 1회 200mg/체중kg 경구 투여하였다.As the experimental animals, male SD rats of 4 weeks old were freely ingested with water and general feed for 10 days, and after completion of the acclimation period, 6 rats per experimental group were placed in a wire cage to adjust the average weight to 200 ± 5g. At this time, 0.5% of Uji (animal oil) and 0.5% of soybean oil (vegetable oil) were mixed and administered to the feed, and a control group to feed only the fat-containing feed was prepared separately. The composition of the extracts was varied, mixed and orally administered 200 mg / kg body weight once a day.

실험군 1 : 두충엽 엑기스 + 감잎 + 산사자 + 월견자 엑기스(7:1:1:1)Experimental group 1: two leaf extract + persimmon leaf + mountain lion + moon dog extract (7: 1: 1: 1)

실험군 2 : 두충엽 엑기스 + 감잎 + 산사자 + 결명자 엑기스(7:1:1:1)Experimental group 2: two leaf extract + persimmon leaf + hawthorn + deficiency extract (7: 1: 1: 1)

실험군 3 : 두충엽 엑기스 + 감잎 + 황금 + 결명자 엑기스(7:1:1:1)Experimental group 3: two leaf extract + persimmon leaf + golden + missing extract (7: 1: 1: 1)

실험군 4 : 두충엽 엑기스 + 동규자 + 산사자 + 결명자 엑기스(7:1:1:1)Experimental group 4: two leaf extract + Donggyuja + mountain lion + gyeolja extract (7: 1: 1: 1)

실험군 5 : 두충엽 엑기스 + 결명자 + 황금 + 동규자 엑기스(7:1:1:1)Experimental group 5: two leaf extract + deficiency + golden + copper rule extract (7: 1: 1: 1)

실험군 6 : 두충엽 엑기스 + 월견자 + 산사자 + 동규자 엑기스(7:1:1:1)Experimental group 6: two leaf extract + moon dog + mountain lion + Donggyuja extract (7: 1: 1: 1)

실험군 7 : 두충엽 엑기스 + 월견자 + 산사자 + 황금 엑기스(7:1:1:1)Experimental group 7: two leaf extract + moon dog + mountain lion + golden extract (7: 1: 1: 1)

2주 경과시마다 디지탈 저울로 체중을 측정하여, 각군 체중의 평균값을 구하였으며, 하기의 표 8에 그 결과를 나타내었다.The weight of each group was measured with a digital balance every two weeks, and the average value of the weight of each group was obtained. The results are shown in Table 8 below.

표 8. 두충엽 엑기스 + 생약재 엑기스이 혼합 따른 각 실헙군의 체중변화Table 8. Changes in body weight of each group following the mixing of the two leaf extracts and the herbal extracts

Claims (2)

두충엽을 주원료로 함우하고; 감잎, 월견자, 산사자, 결명자, 황금 및 동규자로 이루어진 군에서 선택된 1종 이상의 생액재를 두충엽과 생약재를 합한 중량에 대해 30중량% 이하가 되는 양으로 함유함을 특징으로 하는 건강식품 조성물.Two main leaves were treated as main raw materials; A health food composition, characterized in that it contains at least 30% by weight of the total weight of the two leaves and herbal medicines selected from the group consisting of persimmon leaves, moon dogs, hawthorn, clarifiers, golden and copper gyubu. 제1항에 있어서, 건강식품 조성물은 차, 음료, 과립, 정제 또는 경질캡슐의 제형임을 특징으로 하는 건강식품 조성물.The health food composition of claim 1, wherein the health food composition is a formulation of tea, beverage, granules, tablets or hard capsules.
KR1019950005354A 1995-03-15 1995-03-15 Health food containing leaf of eucommia ulmoides oliver KR0137897B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950005354A KR0137897B1 (en) 1995-03-15 1995-03-15 Health food containing leaf of eucommia ulmoides oliver

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950005354A KR0137897B1 (en) 1995-03-15 1995-03-15 Health food containing leaf of eucommia ulmoides oliver

Publications (2)

Publication Number Publication Date
KR960033299A KR960033299A (en) 1996-10-22
KR0137897B1 true KR0137897B1 (en) 1998-04-25

Family

ID=19409835

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950005354A KR0137897B1 (en) 1995-03-15 1995-03-15 Health food containing leaf of eucommia ulmoides oliver

Country Status (1)

Country Link
KR (1) KR0137897B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100496622B1 (en) * 2002-04-29 2005-06-29 (주) 김형민한약연구소 Alcohol fermented food or pharmaceutical composition for prevention of obesity and process for preparation thereof
KR20190100596A (en) * 2018-02-21 2019-08-29 금산군 Anti-obesity composition containing extract of fermented extract of medicinal herbs and method for preparing the same

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020026063A (en) * 2000-09-30 2002-04-06 최종원 Method for Manufacturing A Drink for Health Care
KR20030024111A (en) * 2001-09-17 2003-03-26 (주)바이오뉴트리젠 Composition for lowering blood lipid level comprising a dyospyros kaki leaf extract

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100496622B1 (en) * 2002-04-29 2005-06-29 (주) 김형민한약연구소 Alcohol fermented food or pharmaceutical composition for prevention of obesity and process for preparation thereof
KR20190100596A (en) * 2018-02-21 2019-08-29 금산군 Anti-obesity composition containing extract of fermented extract of medicinal herbs and method for preparing the same

Also Published As

Publication number Publication date
KR960033299A (en) 1996-10-22

Similar Documents

Publication Publication Date Title
KR101738912B1 (en) Composition For Anti-obesity And Diet
CN102599322A (en) Tablet candy suitable for children and manufacturing method thereof
KR100947278B1 (en) A carbohydrate and lipid absorption inhibitory nelumbo composition and its manufacturing process thereof
KR20160032851A (en) METHOD OF MANUFACTURING PILL COMPRISED OF Protaetia brevitarsis seulensis
CN106266112A (en) A kind of compound Chinese medicinal preparation of invigorating the spleen to arrest diarrhea and preparation method thereof
KR100891914B1 (en) The method of preparing the functional food for diet using extrative extrated from madicin-matrrials of plants
KR20190033828A (en) Compositions for preventing, ameliorating or treating hyperuricemia or metabolic disorders associated with hyperuricemia comprising herbal extracts
KR0137897B1 (en) Health food containing leaf of eucommia ulmoides oliver
KR101910013B1 (en) A composition for improving, preventing and treating of pain comprising herb extract
WO2004058284A1 (en) Anti-obesity ingretients from medicinal plants and their composittion
KR20130029284A (en) Composition of healthy foods for treatment of dementia
CN110063977B (en) Radix codonopsis and sea buckthorn composite electuary and application thereof
JP2007070263A (en) Composition for preventing diabetes mellitus
CN108813500B (en) Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions
KR102045847B1 (en) Kyung-ok-go having high acceptability and anti-diabetes activity adding the silk of zea mays and pumpkin
KR20160059152A (en) Anti-obesity composition comprising Cirsium japonicum leaf extract as effective component
KR20210041387A (en) A natural tea removing the effect of hangover contained the extract material in arrowroot blossoms and Plantago ovata
CN110710672A (en) Natural plant active calcium preparation and preparation method thereof
CN108685101A (en) Wood frog peptide inulin
CN114680215B (en) Composition for improving exercise performance and fatigue recovery comprising fermented and cooked noni, coconut sugar or brown sugar as active ingredient
KR100497845B1 (en) food having herbal medicine for assisting healthy and producing method thereof
CA2988205C (en) Composition for weight reduction comprising a beverage and beads
KR101911628B1 (en) The method of preparing a counteractive using medicinal stuff plant
KR101874842B1 (en) Lotus Root of PreparationMethod Thereof
US20020172730A1 (en) Orals dosage noni formulations

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20000128

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee